⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10530641 | 0.84 | TSHR (0.40) | — | |
| SCHEMBL270381 | 0.82 | — | — | |
| SCHEMBL9368619 | 0.82 | — | — | |
| SCHEMBL277789 | 0.80 | — | — | |
| SCHEMBL276282 | 0.78 | FDPS (0.46) | — | |
| SCHEMBL2670965 | 0.78 | FDPS (0.46) | — | |
| SCHEMBL14732171 | 0.78 | FDPS (0.46) | — | |
| SCHEMBL4699570 | 0.78 | FDPS (0.46) | — | |
| SCHEMBL7263751 | 0.78 | FDPS (0.46) | — | |
| SCHEMBL1831666 | 0.78 | FDPS (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1576 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118159542-A | Substituted 2, 3-dihydro [1,3] thiazolo [4,5-b ] pyridines, salts thereof and their use as herbicidal agents | 拜耳公司 | 2024-06-07 | — | — | CN | claimed |
| WO-2024027844-A1 | PHARMACEUTICAL COMPOSITION AND USE THEREOF | 临港国家实验室 | 2024-02-08 | — | — | WO | claimed |
| CN-117503776-A | Pharmaceutical composition and application thereof | 临港国家实验室 | 2024-02-06 | — | — | CN | claimed |
| WO-2024021261-A1 | METHOD FOR PREPARING ERIBULIN INTERMEDIATE | 上海皓元医药股份有限公司 | 2024-02-01 | — | — | WO | claimed |
| EP-4103983-B1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED C+ COMPENSATION FILMS WITH IMPROVED WAVELENGTH DISPERSION | EASTMAN CHEM CO (US) | 2024-01-24 | — | — | EP | claimed |
| CN-116693479-A | BysspinA derivative, preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2023-09-05 | — | — | CN | claimed |
| WO-2023152709-A1 | RNA POLYMERASE INHIBITORS AND METHODS USING SAME | ARBUTUS BIOPHARMA CORPORATION (CA) | 2023-08-17 | — | — | WO | claimed |
| US-20230138841-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED C+ COMPENSATION FILMS WITH IMPROVED WAVELENGTH DISPERSION | EASTMAN CHEMICAL COMPANY (US) | 2023-05-04 | — | — | US | claimed |
| US-11596716-B2 | Compounds and matrices for use in bone growth and repair | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2023-03-07 | — | — | US | claimed |
| EP-4103983-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED C+ COMPENSATION FILMS WITH IMPROVED WAVELENGTH DISPERSION | Eastman Chemical Company (US) | 2022-12-21 | — | — | EP | claimed |
| US-6262269-B1 | 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries | TREGA BIOSCIENCES, INC. | 2001-07-17 | — | — | US | claimed |
| EP-1053001-A1 | NOVEL MIXED AMYLIN ACTIVITY COMPOUNDS | AMYLIN PHARMACEUTICALS, INC. (US) | 2000-11-22 | — | — | EP | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| EP-0977989-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1999040928-A1 | NOVEL MIXED AMYLIN ACTIVITY COMPOUNDS | AMYLIN PHARMACEUTICALS, INC. (US) | 1999-08-19 | — | — | WO | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| US-5444162-A | Esters of sucrose or lactose as flavor precursors which liberate 3-methylpentanoic acid on heating | UNILEVER PATENT HOLDINGS B.V. (NL) | 1995-08-22 | — | — | US | claimed |
| US-5352689-A | Rhizoxin derivatives and their use as anti-tumor agents | SANKYO COMPANY, LIMITED (JP) | 1994-10-04 | — | — | US | claimed |
| US-4911745-A | Containing a phenyl substituted in position 3 of ring | ICI AMERICAS INC. (US) | 1990-03-27 | — | — | US | claimed |